Considering the reduction in intracellular Mn levels, together with the association of SLC39A8 mutations with the mitochondrial disorder Leigh syndrome, we hypothesized that these mutations may lead to reduced activity of MnSOD, the Mn-requiring antioxidant enzyme in mitochondria. Here, SOD2 is linked to Leigh syndrome.